DBV Technologies (DBVT) Other financing activities (2020 - 2021)

DBV Technologies (DBVT) reported Other financing activities of $6000.0 for Q4 2021, up 150.0% year-over-year from $2400.0 in Q4 2020, and up 250.0% quarter-over-quarter from -$4000.0 in Q3 2021.

DBV Technologies (DBVT) Other financing activities (2020 - 2021) Analysis & Trends

DBV Technologies (DBVT) has 2 years of Other financing activities data on file, last reported at $6000.0 in Q4 2021.

  • Other financing activities for Q4 2021 came in at $6000.0, up 150.0% year-over-year; the trailing twelve-month figure through Sep 2022 was $6000.0 (up 118.18% YoY), and the FY2021 annual result was -$15000.0, up 58.33% from the prior year.
  • Other financing activities climbed to $6000.0 in Q4 2021 per DBVT's latest filing, from -$4000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $6000.0 in Q4 2021 and troughed at -$17000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 6,000.00
Dec 31, 2021 6,000.00
Sep 30, 2021 -4,000.00
Sep 30, 2021 -4,000.00
Mar 31, 2021 -17,000.00
Mar 31, 2021 -17,000.00
Dec 31, 2020 -12,000.00
Dec 31, 2020 -12,000.00
Sep 30, 2020 -5,000.00
Sep 30, 2020 -5,000.00
Jun 30, 2020 -12,000.00
Jun 30, 2020 -12,000.00
Mar 31, 2020 -7,000.00
Mar 31, 2020 -7,000.00